Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials
Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study
Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study
The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study
Clinical evaluation of changes in biomarkers by oral intake of NMN
Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study
Ingestion of β-nicotinamide mononucleotide increased blood NAD+ levels, maintained walking speed, and improved sleep quality in older adults
This study shows that NMN intake for 12 weeks increased blood NAD+ levels, maintained walking speed, and improved sleep quality in older adults.
Therapeutic effect of nicotinamide mononucleotide on Alzheimer's disease
This study demonstrates NMN's potential in treating Alzheimer's disease by enhancing autophagy and reducing oxidative stress.